Acadia Pharmaceuticals Rights Deal and Bullish Outlook Sends Shares Surging 16%. Here’s What to Expect.
Acadia Pharmaceuticals shares surged following the announcement of the company's acquisition of expanded commercial rights for a groundbreaking drug.



















